Toggle navigation
Home
Search
Services
Blog
Contact
About
In Vitro Antineoplastic Drug Toxicology Characterization
Murphy, Martin
Hipple Cancer Research Corporation, Dayton, OH, United States
Search 58 grants from Martin Murphy
Search grants from Hipple Cancer Research Corporation
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Summer Institute in Neuroimaging and Data Science
Mesenchymal Cell Dysfunction in Fibroproliferative Lung Disease
FMRI and EEG approaches to the resting state in ASD
Molecular Lymphosonography for Sentinel Lymph Node Characterization
Oregon/Hawaii Node, Clinical Trials Network
Recently added grants:
GPCR-mediated pathways for regulation of intestinal lymphatic function
Mouse Metabolic Function & Phenotyping Core
Lymphatic remodeling and transport of dietary fats in short gut syndrome
Cytometry & Cell Sorting Core
Role of the intestinal microvasculature in necrotizing enterocolitis
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Division of Cancer Treatment (NCI)
Type
Small Business Innovation Research – Phase II (N44)
Project #
N44CM027361-004
Application #
3609936
Study Section
Project Start
1992-08-01
Project End
1994-07-31
Budget Start
1993-06-30
Budget End
1994-07-31
Support Year
Fiscal Year
1993
Total Cost
Indirect Cost
Institution
Name
Hipple Cancer Research Corporation
Department
Type
DUNS #
City
Dayton
State
OH
Country
United States
Zip Code
45439
Related projects
NIH 1993
N44 CM
In Vitro Antineoplastic Drug Toxicology Characterization
Murphy, Martin / Hipple Cancer Research Corporation
NIH 1992
N44 CM
In Vitro Antineoplastic Drug Toxicology Characterization
Murphy, Martin / Hipple Cancer Research Corporation
Comments
Be the first to comment on Martin Murphy's grant